Submit your email to push it up the queue
Siemens Medical Solutions Diagnostics, Inc., a prominent player in the healthcare industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in the early 2000s, the company has established itself as a leader in medical diagnostics, focusing on innovative solutions that enhance patient care and streamline laboratory processes. Specialising in in-vitro diagnostics, Siemens Medical Solutions offers a diverse range of core products, including advanced diagnostic imaging systems and laboratory automation technologies. Their unique approach combines cutting-edge technology with a commitment to quality, ensuring accurate and timely results for healthcare providers. With a strong market position, Siemens Medical Solutions Diagnostics has achieved notable milestones, including numerous awards for innovation and excellence in healthcare solutions. Their dedication to improving diagnostic accuracy and efficiency continues to set them apart in the competitive landscape of medical diagnostics.
How does Siemens Medical Solutions Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Siemens Medical Solutions Diagnostics, Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Siemens Medical Solutions Diagnostics, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Siemens Aktiengesellschaft, which cascades its climate commitments and targets down to its subsidiaries. Siemens Aktiengesellschaft has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, CDP reporting, and participation in the RE100 initiative, which aims for 100% renewable energy usage. These initiatives reflect a strong corporate commitment to reducing carbon emissions across its operations. While specific reduction targets for Siemens Medical Solutions Diagnostics, Inc. are not available, the overarching goals set by Siemens Aktiengesellschaft suggest a focus on sustainability and significant reductions in greenhouse gas emissions. The company is aligned with industry standards for climate action, although detailed metrics and specific targets for this subsidiary have not been disclosed.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | 963,740 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siemens Medical Solutions Diagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.